The Protective Role of Vitamin C on Endothelial Dysfunction

Journal of Clinical and Basic Cardiology

Volumn 6, Issue 1-4, 2003, Pages 3-6

  Korantzopoulos, P ^a   Galaris, Dimitrios ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Antioxidants; Endothelium; Oxidative stress; Vitamin C

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; GUANYLATE CYCLASE; NITRIC OXIDE; NITROSO DERIVATIVE; REACTIVE OXYGEN METABOLITE; TETRAHYDROBIOPTERIN;

CELL ADHESION; CELL FUNCTION; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0346753900     PISSN: 15612775     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Drexler H, Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999; 31: 51-60.
2. Fargione MA, Leopold JA, Loscalzo J. Roles of endothelial dysfunction in coronary artery disease. Curr Opin Cardiol 2000; 15: 409-15.
3. Newby DE, Wright RA, Labinjoh C, Lundlam CA, Fox KA, Boon NA, Webb DJ. Endothelial dysfunction, impaired endogenous fibrinolysis and cigarette smoking - A mechanism for arterial thrombosis and myocardial infarction. Circulation 1999; 99: 1411-5.
4. Vira JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC. Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-7.
5. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-906.
6. Toutouzas PK, Tousoulis D, Davies GJ. Nitric oxide synthesis in atherosclerosis. Eur Heart J 1998; 19: 1504-11.
7. Duplaa C, Couffinhal T, Labat L, Moreau C, Petit-Jean ME, Doutre MS, Lamaziere JM, Bonnet J. Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions. Atherosclerosis 1996; 121: 253-66.
8. rd ed. Oxford University Press, New York, 1999: 73-82.
9. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986: 315: 1046-51.
10. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress. Circ Res 2000; 87: 840-4.
11. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655-73.
12. Barbouti A, Doulias P-T, Zhu B-Z, Frei B, Galaris D. Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA damage. Free Radic Biol Med 2001; 31: 490-8.
13. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992; 89: 10-8.
14. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271: C1424-37.
15. Doulias P-T, Barbouti A, Galaris D, Ischiropoulos H. SIN-1-induced DNA damage in isolated human blood lymphocytes as assesed by single cell gel electrophoresis (comet assay). Free Radic Biol Med 2001; 30: 679-85.
16. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karui H, Tordo P, Pritchard KA. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 1998; 95: 9220-5.
17. Khaw K-T, Bingham S, Welch A, Luben R, Wareham N, Oakes S, Day N. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. Lancet 2001; 357: 657-63.
18. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 154-60.
19. Nyysonen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 1997; 314: 634-8.
20. Vita JA, Keaney JF, Raby KE, Morrow JD, Freedman JE, Lynch S, Koulouris SN, Hankin BR, Frei B. Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome. J Am Coll Cardiol 1998; 31: 980-6.
21. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989; 86: 6377-81.
22. Frei B. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc Soc Exp Biol Med 1999; 222: 196-204.
23. Galaris D, Korantzopoulos P. On the molecular mechanism of metmyoglobin-catalyzed reduction of hydrogen peroxide by ascorbate. Free Radic Biol Med 1997; 22: 657-67.
24. Wen Y, Cooke T, Feely J. The effect of pharmacological supplementation with vitamin C on low-density lipoprotein oxidation. Br J Clin Pharmacol 1997; 44: 94-7.
25. rd ed. Oxford University Press, New York, 1999: 48-55.
26. Carr A, Frei B. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J 1999; 13: 1007-24.
27. Halliwel B. Vitamin C: antioxidant or prooxidant in vivo? Free Rad Res 1996; 25: 439-54.
28. Rehman A, Collis CS, Yang M, Kelly M, Diplock AT. Halliwel B, Rice-Evans C. The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Commun 1998; 246: 293-8.
29. Conti CR. Vitamin C and coronary vasoreactivity. Eur Heart J 1999; 20: 1615-7.
30. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-41.
31. Levine GN, Frei BN, Koulouris SN, Gerhard MD, Keaney JF, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93: 1107-13.
32. Tousoulis D, Davies G, Toutouzas P. Vitamin C increases nitric oxide availability in coronary atherosclerosis. Ann Intern Med 1999; 131: 156-7.
33. Gokce N, Keaney JF, Frei B, Holbrook M, Olesiak M, Zachariah BJ, Leeuwenburgh C, Heinecke C, Vita JA. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999; 99: 3234-40.
34. Kugiyama K, Motoyama T, Hirashima O, Ohgushi M, Soejima H, Misumi K, Kawano H, Miyao Y, Yoshimura M, Ogawa H, Matsamura T, Sugiyama S, Yasue H. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1998; 32: 103-9.
35. Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998; 97: 363-8.
36. Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997; 96: 1513-9.
37. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide in essential hypertension. Circulation 1998; 97: 2222-9.
38. Sherman DL, Keaney JF, Biegelsen ES, Duffy SJ, Coffman JD, Vita JA. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 2000; 35: 936-41.
39. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997; 95: 2617-22.
40. Timimi FK, Ting HH, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998; 31: 552-7.
41. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996; 97: 22-8.
42. Wratten M-L, Tetta C, Ursini F, Sevanian A. Oxidant stress in hemodialysis: Prevention and treatment strategies. Kidney Int 2000; 58: S126-32.
43. Heitzer T, Just H, Münzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996; 94: 6-9.
44. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, Mattioli PL. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes 2001; 50: 159-65.
45. Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia - an effect reversible with vitamin C therapy. Circulation 1999; 99: 1156-60.
46. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 1996; 98: 5-7.
47. Kaufmann PA, Gnecchi-Ruscone T, Terlizzi M, Schafers KP, Luscher TF, Camici PG. Coronary heart disease in smokers: vitamin C restores microcirculatory function. Circulation 2000; 102: 1233-8.
48. Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF, Vita JA. Treatment of hypertension with ascorbic acid. Lancet 1999; 354: 2048-9.
49. May JM. How does ascorbic acid prevent endothelial dysfunction? Free Radic Biol Med 2000; 28: 1421-9.
50. Levine M, Conry-Cantilena C, Wang YH, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 1996; 93: 3704-9.
51. Bergsten P, Amitai G, Kehrl J, Dhariwal KR, Klein HG, Levine M. Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes. Depletion and reaccumulation. J Biol Chem 1990; 265: 2584-7.
52. Ek A, Ström K, Cotgreave IA. The uptake of ascorbic acid into human umbilicial vein endothelial cells and its effect on oxidant insult. Biochem Pharmacol 1995; 50: 1339-46.
53. Martin A, Frei B. Both intracellular and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells. Arterioscler Thromb Vasc Biol 1997; 17: 1583-90.
54. Weber C, Wolfgang E, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996; 93: 1488-92.
55. Ellis GR, Anderson RA, Lang D, Blackman DJ, Morris RHK, Morris-Thurgood J, McDowell IF, Jackson SK, Lewis MJ, Frenneaux MP. Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy. J Am Coll Cardiol 2000; 36: 1474-82.
56. Heller R, Münscher-Paulig F, Grabner R, Till U. L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem 1999; 274: 8254-60.
57. Huang A, Vita JA, Venema RC, Keaney JF. Ascorbic acid enhances endothelial nitric oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 2000; 275: 17399-406.
58. Scroza G, Pitraforte D, Minetti M. Role of ascorbate and protein thiols in the release of nitric oxide from S-nitoso-albumin and S-nitroso-glutathione in human plasma. Free Radic Biol Med 1997; 22: 633-42.
59. Mirvish SS, Wallcave L, Eagen M, Shubik P. Ascorbate-nitrite reaction: possible means of blocking the formation of carcinogenic N-nitroso compounds. Science 1972; 177: 65-8
60. Bassenge E, Fink N, Skatchkov M, Fink B. Dietary supplement with vitamin C prevents nitrate tolerance. J Clin Invest 1998; 102: 67-71.